UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Daichi Sankyo, BMS in neck-and-neck competition over blood thinners
The competition among drugmakers over non-vitamin K antagonist oral anticoa...
by So Jae-hyeon
|
2018-11-23 16:18
라인
Prescription drug sales surge in October
Sales of prescription medicines grew significantly in October, compared to ...
by So Jae-hyeon
|
2018-11-23 11:42
라인
Retailers, pharmacies fear profit fall amid mushrooming dementia drugs
Pharmaceutical companies are intensively competing to promote their dementi...
by So Jae-hyeon
|
2018-11-22 15:23
라인
Intron Bio inks ₩750 billion licensing deal for anti-superbug drug
Intron Biotechnology said it has signed a landmark deal for an investigatio...
by So Jae-hyeon
|
2018-11-20 15:00
라인
Licensing-out deals boost pharmaceutical shares
Pharmaceutical shares rose on Monday on two licensing-out deals by mid-size...
by So Jae-hyeon
|
2018-11-20 14:02
라인
[News Focus] Biotechs to suffer shocks from Samsung BioLogics mess
The stock trading suspension of Samsung BioLogics due to the alleged accoun...
by So Jae-hyeon
|
2018-11-15 14:56
라인
Chong Kun Dang challenges to beat Pfizer’s rheumatoid arthritis drug
While domestic pharmaceutical firms voluntarily withdrew patent suits again...
by So Jae-hyeon
|
2018-11-13 15:03
라인
Which drugmakers will mark over ₩1 trillion sales this year?
Pharmaceutical industry officials are paying keen attention which companies...
by So Jae-hyeon
|
2018-11-13 13:08
라인
Korea Vaccine in tight spot due to tainted BCG, dosshouse fire
Korea Vaccine has emerged as the center of controversy, as it is involved i...
by So Jae-hyeon
|
2018-11-12 17:13
라인
Daewoong’s botulinum toxin wins indication for crow’s feet
Daewoong Pharmaceutical said it has expanded the indication of Nabota, the ...
by So Jae-hyeon
|
2018-11-09 15:27
라인
[Exclusive] Wholesaler allegedly smuggled obesity drug Saxenda into China
A Korean wholesaler has allegedly smuggled popular obesity drug Saxenda int...
by So Jae-hyeon
|
2018-11-09 14:59
라인
Hanmi rolls out new generic drug to beat Pfizer’s anti-nicotine therapy
After failing to outrival Pfizer in the anti-smoking treatment market with ...
by So Jae-hyeon
|
2018-11-07 16:07
라인
Biois seeks KOSDAQ listing with ‘technology exception policy’
Biois Corp. said it would utilize the government’s “technology exception po...
by So Jae-hyeon
|
2018-11-06 15:43
라인
Celltrion wins suit against Roche to invalidate Herceptin patent in Japan
Korea’s biosimilar company Celltrion is likely to accelerate its move to ex...
by So Jae-hyeon
|
2018-11-05 15:26
라인
Why did pharmaceuticals release hair loss drugs in tablet form?
Why have Korean pharmaceutical companies released hair loss treatments in t...
by So Jae-hyeon
|
2018-11-02 12:43
라인
Venture firm finds ‘way’ for tricky diagnosis of irregular heartbeat
Arrhythmia, caused by irregular pulses -- too fast (tachycardia), too slow ...
by So Jae-hyeon
|
2018-10-31 15:21
라인
Generics threaten originals in dementia drug market
Generic products are showing tremendous growth in the market of Donepezil, ...
by So Jae-hyeon
|
2018-10-30 14:18
라인
‘I will help make Korea original holder of anticancer drugs’
“Original technologies are important for national development. We will deve...
by So Jae-hyeon
|
2018-10-29 14:43
라인
Pfizer’s generic business turn ‘disastrous’ amid cancer controversy
Multinational pharmaceutical giant Pfizer’s generic business in Korea is no...
by So Jae-hyeon
|
2018-10-26 17:14
라인
‘Handok encouraged unlicensed medical practice for pharmacists’
Pharmaceutical firm Handok allegedly encouraged pharmacists to carry out un...
by So Jae-hyeon
|
2018-10-25 15:06
-
1
2
3
4
5
6
7
8
9
10
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top